EZETIMIBE; SIMVASTATIN | A208699 | GLENMARK PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.4524
per ea
Lowest NADAC/Unit
$0.3013
per ea
Brand NDCs
0
Generic NDCs
13
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16714078102EZETIMIBE-SIMVASTATIN 10-80 MG | $0.4524 | EA | Generic | — | 2026-06-17 |
| 68462032430EZETIMIBE-SIMVASTATIN 10-80 MG | $0.4524 | EA | Generic | — | 2026-06-17 |
| 68462032490EZETIMIBE-SIMVASTATIN 10-80 MG | $0.4524 | EA | Generic | — | 2026-06-17 |
| 16714078101EZETIMIBE-SIMVASTATIN 10-80 MG | $0.4524 | EA | Generic | — | 2026-06-17 |
| 68462032190EZETIMIBE-SIMVASTATIN 10-10 MG | $0.3810 | EA | Generic | — | 2026-06-17 |
| 68462032130EZETIMIBE-SIMVASTATIN 10-10 MG | $0.3810 | EA | Generic | — | 2026-06-17 |
Showing 6 of 13 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.